Insider · CIK 0001858528
Thomas A. Vecchiolla
Files at CLDI (Calidi Biotherapeutics, Inc.). First filing -, latest -.
In brief
Thomas A. Vecchiolla files SEC Form 4 as director at CLDI (Calidi Biotherapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Thomas A. Vecchiolla has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 21, 2023 | CLDI Calidi Biotherapeutics, Inc. | AGrant or award Common Stock | +7,709 | $1.80 | $14k | 365,105 | Dec 26, 2023 |
Questions about Thomas A. Vecchiolla
Answered from the filings on this page, as of the latest one.
Is Thomas A. Vecchiolla buying or selling?
Thomas A. Vecchiolla has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Thomas A. Vecchiolla's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas A. Vecchiolla has 0.
Where does Thomas A. Vecchiolla file Form 4?
Thomas A. Vecchiolla has filed Form 4 at CLDI (Calidi Biotherapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.